Group 1 - The stock price of Sanyuan Bio (301206.SZ) fell by 4.07% to 28.55 yuan as of the market close on February 27 [1] - Sanyuan Bio was listed on the Shenzhen Stock Exchange's ChiNext board on February 10, 2022, with an initial public offering (IPO) of 33.721 million shares at a price of 109.30 yuan per share [1][2] - On its first trading day, Sanyuan Bio reached a peak price of 146.00 yuan, but is currently in a state of decline [2] Group 2 - The total funds raised from the IPO amounted to 3.686 billion yuan, with a net amount of 3.547 billion yuan after deducting issuance costs [2] - The net funds raised exceeded the original plan by 2.647 billion yuan, as the company initially aimed to raise 900 million yuan for various projects [2] - The total issuance costs for the IPO were 139 million yuan, including 121 million yuan for underwriting and sponsorship fees [3] Group 3 - In 2021, Sanyuan Bio announced a dividend distribution plan, distributing 10 yuan in cash per 10 shares (including tax) and a bonus of 5 shares for every 10 shares held [3] - The total share capital before the dividend distribution was 135 million shares, which increased to 202 million shares after the distribution [3] - The record date for the dividend distribution was June 16, 2022, and the ex-dividend date was June 17, 2022 [3]
三元生物跌4.07% 2022上市即顶超募26亿中信建投保荐